EU to investigate complaints that certain anti-obesity drugs cause suicidal thoughts
[ad_1]
European Medicines Agency (EMA) Start a review of several popular drugs by the Danish pharmaceutical company Novo Nordisk after complaints that the drugs could cause depression, even self-harm and suicidal ideation. We are talking about the drugs Saxenda and Wegovy, used for weight loss, as well as Ozempic, used to treat type 2 diabetes. The review follows complaints of two cases of suicidal ideation and one case of self-harm from Icelandic citizens taking Novo Nordisk for diabetes and/or obesity.
The EMA will study the effects of the common active ingredient semagludite on the psyche and, based on the results of the test, Maybe include these effects in the list of side effects. Novo Nordisk noted that its clinical trials have shown no such effect on the psyche. However, the company emphasized that it is attentive to all signals from patients and is ready to contribute to research.
[ad_2]
Source link
